Tag: FDA guidance 2025

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
wayne Holloway in: Medications 16 January 2026

The FDA's 2025 guidance streamlines biosimilar approval by replacing costly clinical trials with advanced analytical data, accelerating access to lower-cost biologic alternatives for cancer, arthritis, and diabetes. Learn how the process works and what's still holding it back.

view more
Go!

recent posts

Labor Cost Differences: Generic vs Brand Drug Production Explained
Labor Cost Differences: Generic vs Brand Drug Production Explained

Generic drugs cost far less than brand-name drugs not because ingredients are cheaper, but because labor costs are structured differently. Learn how scale, regulation, and global production shape the real cost of your prescriptions.

Published ON: 9 Feb
Why Brand Companies Launch Authorized Generics: Strategy Explained
Why Brand Companies Launch Authorized Generics: Strategy Explained

Brand companies launch authorized generics to protect revenue when patents expire. These are identical to the original drug but sold at lower prices, undercutting competitors and keeping patients loyal. It’s a smart business move - and it saves consumers money.

Published ON: 23 Feb
How to Track Post-Marketing Studies for Drug Safety
How to Track Post-Marketing Studies for Drug Safety

Learn how post-marketing studies track drug safety after approval, using FAERS, Sentinel, and real-world data to catch hidden risks. Understand the systems, challenges, and future of pharmacovigilance.

Published ON: 11 Feb
Edema in CKD: How Diuretics, Salt Restriction, and Compression Therapy Work Together
Edema in CKD: How Diuretics, Salt Restriction, and Compression Therapy Work Together

Edema in CKD is caused by fluid buildup from failing kidneys. Managing it requires a three-part strategy: the right diuretics, strict salt restriction, and compression therapy. Learn how each works-and how to use them safely.

Published ON: 7 Feb
Workplace Wellness: How to Educate Employees About Generic Benefits That Actually Stick
Workplace Wellness: How to Educate Employees About Generic Benefits That Actually Stick

Most workplace wellness programs fail because employees don’t understand how they benefit. Learn how to educate staff with clear, personalized messaging that boosts participation, cuts costs, and builds trust.

Published ON: 1 Feb

categories

archives

tags

online pharmacy side effects health benefits dietary supplement benefits coping strategies alternatives treatment erectile dysfunction medication side effects generic drugs mental health drug interactions medication safety generic medications dietary supplements desloratadine bipolar disorder risks cancer treatment